Pub. Date : 2017 Apr
PMID : 28413487
4 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Vandetanib and ADAM inhibitors synergistically attenuate the pathological migration of EBV-infected retinal pigment epithelial cells by regulating the VEGF-mediated MAPK pathway. | vandetanib | vascular endothelial growth factor A | Homo sapiens |
| 2 | Vandetanib is an oral anticancer drug that selectively inhibits the activities of VEGF receptor and epidermal growth factor receptor tyrosine kinase; however, the effects of vandetanib on VEGF in retinal pigment epithelial (RPE) cells have not yet been studied. | vandetanib | vascular endothelial growth factor A | Homo sapiens |
| 3 | Vandetanib is an oral anticancer drug that selectively inhibits the activities of VEGF receptor and epidermal growth factor receptor tyrosine kinase; however, the effects of vandetanib on VEGF in retinal pigment epithelial (RPE) cells have not yet been studied. | vandetanib | vascular endothelial growth factor A | Homo sapiens |
| 4 | The migratory activity of ARPE19/EBV induced by VEGF was efficiently blocked by vandetanib. | vandetanib | vascular endothelial growth factor A | Homo sapiens |